Clear cell sarcoma of the esophagus: A rare location.

chemotherapy clear cell sarcoma esophagus gastrointestinal

Journal

Clinical case reports
ISSN: 2050-0904
Titre abrégé: Clin Case Rep
Pays: England
ID NLM: 101620385

Informations de publication

Date de publication:
Feb 2020
Historique:
received: 10 09 2019
revised: 23 11 2019
accepted: 01 12 2019
entrez: 5 3 2020
pubmed: 5 3 2020
medline: 5 3 2020
Statut: epublish

Résumé

Clear cell sarcoma of the esophagus is very rare. The etiology of this neoplasm remains unknown. Confirmed diagnosis requires histopathology with immunochemistry and molecular study. CCS typically shows highly aggressive behavior with a high rate of local recurrence, metastases, and death from disease.

Identifiants

pubmed: 32128181
doi: 10.1002/ccr3.2620
pii: CCR32620
pmc: PMC7044402
doi:

Types de publication

Case Reports

Langues

eng

Pagination

323-326

Informations de copyright

© 2019 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.

Déclaration de conflit d'intérêts

None declared.

Références

Am J Surg Pathol. 2008 Jun;32(6):858-66
pubmed: 18408594
Arch Pathol Lab Med. 2007 Jan;131(1):152-6
pubmed: 17227118
Clin Cancer Res. 2006 Sep 15;12(18):5356-62
pubmed: 17000668
Clin J Gastroenterol. 2014 Jun;7(3):228-32
pubmed: 26183741
Cancer. 2012 Dec 1;118(23):5894-902
pubmed: 22605650
Am J Surg Pathol. 2008 Mar;32(3):452-60
pubmed: 18300804
Clin Sarcoma Res. 2012 Oct 04;2(1):15
pubmed: 23036192
Mod Pathol. 2009 Sep;22(9):1201-9
pubmed: 19561568
Am J Surg Pathol. 2012 Jun;36(6):857-68
pubmed: 22592145
Ann Oncol. 2017 Dec 1;28(12):3000-3008
pubmed: 28950372
Semin Oncol. 1997 Oct;24(5):504-14
pubmed: 9344316
Ann Oncol. 2012 Mar;23(3):807-9
pubmed: 22274882
Clin Cancer Res. 2016 Mar 15;22(6):1364-70
pubmed: 26534966
Arch Pathol Lab Med. 2015 Mar;139(3):407-12
pubmed: 25724038
Pathology. 2018 Aug;50(5):490-498
pubmed: 29970252

Auteurs

Yosra Yahyaoui (Y)

Medical Oncology Department Faculty of Medicine of Tunis Salah Azaiez Institute El Manar University Tunis Tunisia.

Yosr Zenzri (Y)

Medical Oncology Department Faculty of Medicine of Tunis Salah Azaiez Institute El Manar University Tunis Tunisia.

Khalil Behi (K)

Medical Oncology Department Faculty of Medicine of Tunis Salah Azaiez Institute El Manar University Tunis Tunisia.

Nadia Boujelbene (N)

Pathology Department Faculty of Medicine of Tunis Salah Azaiez Institute El Manar University Tunis Tunisia.

Amina Mokrani (A)

Medical Oncology Department Faculty of Medicine of Tunis Salah Azaiez Institute El Manar University Tunis Tunisia.

Imen Abbas (I)

Pathology Department Faculty of Medicine of Tunis Salah Azaiez Institute El Manar University Tunis Tunisia.

Karima Mrad (K)

Pathology Department Faculty of Medicine of Tunis Salah Azaiez Institute El Manar University Tunis Tunisia.

Amel Mezlini (A)

Medical Oncology Department Faculty of Medicine of Tunis Salah Azaiez Institute El Manar University Tunis Tunisia.

Classifications MeSH